• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗效力和效果中的直接和间接影响。

Direct and indirect effects in vaccine efficacy and effectiveness.

作者信息

Halloran M E, Haber M, Longini I M, Struchiner C J

机构信息

Division of Biostatistics, Emory University School of Public Health, Atlanta, GA 30329.

出版信息

Am J Epidemiol. 1991 Feb 15;133(4):323-31. doi: 10.1093/oxfordjournals.aje.a115884.

DOI:10.1093/oxfordjournals.aje.a115884
PMID:1899778
Abstract

In 1915, Greenwood and Yule noted that for valid vaccine efficacy studies, exposure to infection in the vaccinated and the unvaccinated must be equal (Proc R Soc Med 1915;8(part 2):113-94). The direct effect of a vaccine, however, needs to be defined by the protection it confers given a specific amount of exposure to infection, not just a comparable exposure. In this paper, two classes of parameters are distinguished along lines differing from the conventional distinction between efficacy and effectiveness. Efficacy parameters attempt to control for exposure to infection and represent direct effects on individuals. Direct effectiveness parameters represent a mixture of direct effects on individuals and indirect effects in the population.

摘要

1915年,格林伍德和尤尔指出,对于有效的疫苗效力研究,接种疫苗者和未接种疫苗者的感染暴露情况必须相同(《皇家医学会学报》,1915年;8(第2部分):113 - 94)。然而,疫苗的直接效应需要根据在特定感染暴露量下所提供的保护来定义,而不仅仅是可比的暴露情况。在本文中,两类参数的区分方式与效力和效果之间的传统区分不同。效力参数试图控制感染暴露情况,并代表对个体的直接效应。直接效果参数代表对个体的直接效应和人群中的间接效应的混合。

相似文献

1
Direct and indirect effects in vaccine efficacy and effectiveness.疫苗效力和效果中的直接和间接影响。
Am J Epidemiol. 1991 Feb 15;133(4):323-31. doi: 10.1093/oxfordjournals.aje.a115884.
2
Measures of the effects of vaccination in a randomly mixing population.在随机混合人群中疫苗接种效果的衡量指标。
Int J Epidemiol. 1991 Mar;20(1):300-10. doi: 10.1093/ije/20.1.300.
3
Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.在新加坡,结合型肺炎球菌疫苗接种的成本效益:7 价、10 价和 13 价疫苗的比较估计。
Vaccine. 2011 Sep 2;29(38):6686-94. doi: 10.1016/j.vaccine.2011.06.091. Epub 2011 Jul 13.
4
Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies.通过病例对照研究评估疫苗接种效果和疫苗效力。
Epidemiol Rev. 1994;16(1):77-89. doi: 10.1093/oxfordjournals.epirev.a036147.
5
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.在桑给巴尔实施口服霍乱疫苗的效果:大规模疫苗接种运动和观察性队列研究的结果。
Lancet Infect Dis. 2012 Nov;12(11):837-44. doi: 10.1016/S1473-3099(12)70196-2. Epub 2012 Sep 4.
6
The impact of indirect benefits of vaccination on postlicensure vaccine effectiveness estimates: A scenario analysis.疫苗接种间接效益对疫苗上市后效力估计的影响:情景分析。
Vaccine. 2010 Nov 23;28(50):7987-92. doi: 10.1016/j.vaccine.2010.09.044. Epub 2010 Sep 25.
7
Impact of a vaccination programme in children vaccinated with ProQuad, and ProQuad-specific effectiveness against varicella in the Veneto region of Italy.意大利威尼托地区接种百白破-无细胞型百日咳-脊髓灰质炎和 Hib 联合疫苗(ProQuad)儿童的疫苗接种计划的影响和 ProQuad 对水痘的特定效果。
BMC Infect Dis. 2018 Mar 5;18(1):103. doi: 10.1186/s12879-018-3017-9.
8
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?一剂水痘疫苗无法预防学校爆发疫情:是时候接种第二剂了吗?
Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085.
9
Field study on the use of vaccination to control the occurrence of lumpy skin disease in Ethiopian cattle.关于使用疫苗接种控制埃塞俄比亚牛群结节性皮肤病发生情况的实地研究。
Prev Vet Med. 2017 Nov 1;147:34-41. doi: 10.1016/j.prevetmed.2017.08.019. Epub 2017 Oct 27.
10
Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: cohort and case-control study.西班牙纳瓦拉地区 2001 至 2014 年 13 价肺炎球菌结合疫苗对儿童侵袭性肺炎球菌病的直接、间接和总影响:队列和病例对照研究。
Euro Surveill. 2016;21(14). doi: 10.2807/1560-7917.ES.2016.21.14.30186.

引用本文的文献

1
Over- and under-estimation of vaccine effectiveness.疫苗效力的高估与低估。
BMC Med Res Methodol. 2025 Jul 1;25(1):163. doi: 10.1186/s12874-025-02611-4.
2
Assessing Spillover Effects of Medications for Opioid Use Disorder on HIV Risk Behaviors among a Network of People Who Inject Drugs.评估阿片类物质使用障碍药物对注射吸毒者网络中艾滋病毒风险行为的溢出效应。
Stats (Basel). 2024 Jun;7(2):549-575. doi: 10.3390/stats7020034. Epub 2024 Jun 19.
3
Quantifying the direct and indirect components of COVID-19 vaccine effectiveness during the Delta variant era.
量化德尔塔变异株时期新冠病毒疫苗有效性的直接和间接组成部分。
Epidemiol Infect. 2025 Mar 24;153:e59. doi: 10.1017/S0950268825000354.
4
Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity.通过疫苗和感染获得性免疫对SARS-CoV-2感染进行间接保护的强度和持久性。
Nat Commun. 2025 Jan 29;16(1):1090. doi: 10.1038/s41467-024-55029-9.
5
Estimated Effectiveness of Influenza Vaccines in Preventing Secondary Infections in Households.流感疫苗预防家庭内继发感染的效果估计。
JAMA Netw Open. 2024 Nov 4;7(11):e2446814. doi: 10.1001/jamanetworkopen.2024.46814.
6
Quantifying indirect and direct vaccination effects arising in the SIR model.量化 SIR 模型中出现的间接和直接疫苗接种效果。
J R Soc Interface. 2024 Sep;21(218):20240299. doi: 10.1098/rsif.2024.0299. Epub 2024 Sep 18.
7
Indirect protection from rotavirus vaccines: a systematic review.轮状病毒疫苗的间接保护作用:系统评价。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):789-795. doi: 10.1080/14760584.2024.2395534. Epub 2024 Sep 1.
8
Effectiveness of mRNA Booster Vaccine Against Coronavirus Disease 2019 Infection and Severe Outcomes Among Persons With and Without Immune Dysfunction: A Retrospective Cohort Study of National Electronic Medical Record Data in the United States.mRNA加强疫苗对有和无免疫功能障碍的人预防2019冠状病毒病感染及严重后果的有效性:一项基于美国国家电子病历数据的回顾性队列研究
Open Forum Infect Dis. 2024 Jan 11;11(2):ofae019. doi: 10.1093/ofid/ofae019. eCollection 2024 Feb.
9
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design.估算既往感染在预防再次感染方面提供的保护:应用病例对照研究设计。
Am J Epidemiol. 2024 Jun 3;193(6):883-897. doi: 10.1093/aje/kwad239.
10
Influenza Vaccine Effectiveness Against Influenza-Associated Hospitalization in Hong Kong Children Aged 9 Months to 17 Years, March-June 2023.2023 年 3 月至 6 月,香港 9 个月至 17 岁儿童中流感疫苗对与流感相关的住院的有效性。
J Pediatric Infect Dis Soc. 2023 Nov 30;12(11):586-589. doi: 10.1093/jpids/piad083.